PV Bulletin

CAROTONE skin-brightening products found to contain undeclared prescription-only medicine

The TGA is advising consumers that CAROTONE products marketed for skin brightening may pose a serious risk to health.

Primary source: Safety monitoring and information

PV Impact Brief

Urgency: HighConfidence: high

What changed

A safety alert has been issued regarding CAROTONE skin-brightening products, highlighting the presence of undeclared prescription-only medicines.

Why it matters

This alert is crucial as it addresses potential health risks associated with the use of non-compliant skin-brightening products, emphasizing consumer safety.

Action needed

Health professionals and stakeholders should review the safety signals linked to CAROTONE products in their signal management processes.

Relevant for
Medical Safety Lead
Processes impacted
Signal Management
Owner

Regulatory Intelligence Lead

Review cadence

Review in the next regulatory intelligence cycle.

Evidence and confidence

Confidence: highSource updated: Aug 25, 2026

Full briefing

Practical implication

Health professionals and stakeholders should review the safety signals linked to CAROTONE products in their signal management processes.

The TGA has issued an alert regarding CAROTONE skin-brightening products that contain undeclared prescription-only medicine, indicating a potential serious health risk for consumers.

What changed: A safety alert has been issued regarding CAROTONE skin-brightening products, highlighting the presence of undeclared prescription-only medicines.

Why it matters: This alert is crucial as it addresses potential health risks associated with the use of non-compliant skin-brightening products, emphasizing consumer safety.

Practical implication: Health professionals and stakeholders should review the safety signals linked to CAROTONE products in their signal management processes.

View original source

  • Source: TGA Safety Alerts - Safety information
  • Published at source: 2026-08-25T12:00:00.000Z
  • Discovered by monitor: 2026-08-25T15:26:15.851Z

Published from the regulator source ingestion pipeline after PV impact triage.

#Safety Signal#Safety Signals#Australia#Source-ingestion#Regulator-monitor#Tga.gov.au

Related updates for your role

publicEuropean Medicines Agency · European Union · Updated Aug 26, 2026

QRD Guidance on Abbreviations and Pictograms for Veterinary Medicines

Urgency: High

Marketing authorization holders (MAHs) must review and potentially update their product labeling to align with the new regulations by 11 April 2029 for products authorized before 11 May 2024.

Signal ManagementRegulatory Intelligence Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicNPRA, Malaysia · Malaysia · Updated Aug 26, 2026

National Centre for Adverse Drug Reaction Monitoring Annual Report

Urgency: High

Healthcare organizations should review the NPRA annual report to ensure compliance with updated safety monitoring practices and adjust their reporting and signal management processes accordingly.

Signal ManagementRegulatory Intelligence Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicMHRA · UK · Updated Aug 26, 2026

Increased risk of wear and corrosion identified with certain cobalt chrome modular neck hip replacements

Urgency: High

Healthcare providers must implement a follow-up process for patients with identified cobalt-chrome modular neck components, monitoring for new or unexpected symptoms including pain, stiffness, or instability.

Signal ManagementMedical Safety Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: Medical Safety Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicFDA · USA · Updated Aug 26, 2026

Early Alert: Heart Pump Controller Purge Cassette Issue from Abiomed

Urgency: High

Affected healthcare facilities should remove all Automated Impella Controllers from use and stock, ensure annual preventive maintenance is followed, and report any adverse reactions to Abiomed or MedWatch.

Signal ManagementRegulatory Intelligence Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead, Medical Safety Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward